Trial Profile
Impact of Temsirolimus Therapy on Circulating Tumor Cell Biology In Men With Castration Resistant Metastatic Prostate Cancer.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Temsirolimus (Primary) ; Diphenhydramine; Diphenhydramine
- Indications Prostate cancer
- Focus Pharmacodynamics
- 01 Aug 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 04 Jun 2010 One patient had been enrolled by December 2009 according to information presented at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO-2010).
- 14 Jul 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.